Rare Disease Report

Marisa Couluris discusses Losartan to Treat Idiopathic Pulmonary Fibrosis

OCTOBER 26, 2012

Marisa Couluris, D.O., Associate Professor of Pediatrics at the University of South Florida presented a poster at the 2012 DIA/NORD Conference on Rare Diseases and Orphan Products.

Her poster, ‘A pilot project using losartan to treat idiopathic pulmonary fibrosis’  found the antihypertensive agent losartan to stabilize or improve lung function in patients with idiopathic pulmonary function.  This pilot study was well received at the conference and we look forward to seeing more clinical trials to clarify losartan’s efficacy and safety in these patients.

Currently there is no FDA approved treatment for idiopathic pulmonary fibrosis although numerous treatments options are available to reduce or stop progression (corticosteroids, cyclophosphamide, azathioprine, oxygen therapy, etc).

For more information about this condition, please contact Pulmonary Fibrosis Foundation.


Stay informed on the latest rare disease news and developments by signing up for our newsletter.
Copyright © RareDR 2013-2018 Rare Disease Communications. All Rights Reserved.